Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis
J. Clin. Oncol 2021 Jun 17;[EPub Ahead of Print], J Mascarenhas, RS Komrokji, F Palandri, B Martino, D Niederwieser, A Reiter, BL Scott, MR Baer, R Hoffman, O Odenike, AM Vannucchi, J Bussolari, E Zhu, E Rose, L Sherman, S Dougherty, L Sun, F Huang, Y Wan, FM Feller, A Rizo, JJ KiladjianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.